RecallDepth
Class II Ongoing

Valsartan Tablets, USP 160 mg, 90-count bottle (NDC 0591-2169-19), 1000-count bottle (NDC 0591-2169-10), Rx Only, Rx Only, Manufactured by: Arrow Pharma (Malta) Ltd. India, Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054

This recall is currently active, issued August 1, 2018. It was issued by Teva Pharmaceuticals Usa.

Company
Teva Pharmaceuticals Usa
Recall Initiated
July 16, 2018
Posted
August 1, 2018
Recall Number
D-0988-2018
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
15,347 90-count bottles, 8,378 1000-count bottles
Firm Location
North Wales, PA, United States
Official Source
View on FDA website ↗

Reason for Recall

CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

Distribution

Product was distributed throughout the United States, including Hawaii and Puerto Rico

Lot / Code Info

NDC 0591-2169-19 Lot Numbers: 1177880A, 1220831A, 1263941A NDC 0591-2169-10 1175922M, 1220826M, 1236294M, 1240427M, 1270616A

More recalls by Teva Pharmaceuticals Usa

View all recalls by this company →

Other recent Class II Drug recalls